Related Experiment Video
Updated: Apr 19, 2026
12:41
Acquisition of Resting-State Functional Magnetic Resonance Imaging Data in the Rat
Published on: August 28, 2021
5.0K
Dexmedetomidine in current anaesthesia practice- a review
1Assistant Professor, Department of Anaesthesia, HIMSR & HAHCH Jamia Hamdard , New Delhi, India .
Journal of Clinical and Diagnostic Research : JCDR
|December 6, 2014
Summary
Dexmedetomidine, a selective alpha-2 adrenergic agonist, offers versatile applications in anesthesia beyond ICU sedation. This review highlights its analgesic, anesthetic-sparing, and cardiovascular-stabilizing benefits, alongside its role in reducing delirium.
Area of Science:
- Anesthesiology and Pharmacology
Background:
- Dexmedetomidine is a highly selective alpha-2 adrenergic receptor agonist.
- Its applications in anesthesia have expanded significantly beyond intensive care unit (ICU) sedation.
Purpose of the Study:
- To review the current anesthetic applications of dexmedetomidine.
- To raise awareness of its benefits and discuss its limitations.
Main Methods:
- Literature review of clinical studies and anesthetic practice.
Main Results:
- Dexmedetomidine provides analgesia, anesthetic-sparing effects, and sympatholysis.
- It exhibits cardiovascular stabilizing properties and reduces delirium.
- Preserves respiratory function, enhancing its utility in procedural sedation.
Conclusions:
- Dexmedetomidine is a versatile anesthetic agent with a broad range of clinical applications.
- Understanding its benefits and limitations is crucial for optimal patient management.
